VAN WARREN: Open Payments
NPI 1770503849 · CLEVELAND, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,142 in 122 payments from 18 companies in 2025. Trend: 2023 $1,984 · 2024 $2,229 · 2025 $2,142
Food & beverage: $1,966Education: $176
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $358 |
| Amgen Inc. | 15 | $230 |
| AstraZeneca Pharmaceuticals LP | 12 | $220 |
| Alexion Pharmaceuticals, Inc. | 5 | $197 |
| PFIZER INC. | 12 | $184 |
| Janssen Biotech, Inc. | 6 | $179 |
| E.R. Squibb & Sons, L.L.C. | 17 | $144 |
| UCB, Inc. | 6 | $141 |
| Novartis Pharmaceuticals Corporation | 7 | $133 |
| GlaxoSmithKline, LLC. | 4 | $76 |
Products named: RINVOQ, SAPHNELO, XELJANZ, TREMFYA, SKYRIZI, ORENCIA, Bimzelx, COSENTYX.
Industry payments across OH — which companies pay providers there.
